Open-Label Glucocorticoids Modulate Dexamethasone Trial Results in Preterm Infants
Authors:
- 1 October 2010
- journal article
- review article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 126 (4) , e954-e964
Abstract
CONTEXT: Open-label glucocorticoids (OLGs) were often used in trials that investigated postnatal dexamethasone treatment in ventilated preterm infants. OBJECTIVE: To determine if OLG use modulates the dexamethasone treatment effect on mortality, bronchopulmonary dysplasia (BPD), and neurodevelopmental outcome. METHODS: Electronic databases, abstracts from the Pediatric Academic Societies, and results of manual reference searches were used as data sources. Fifteen randomized controlled trials comparing dexamethasone with placebo in 721 ventilated preterm infants older than 7 days were identified. The interaction between dexamethasone treatment effect and OLG use was assessed by meta-regression analysis and subgroup meta-analysis according to the percentage of OLG use in the placebo group. Trials with a moderately early (7- to 14-day) or delayed (>3-week) treatment onset were analyzed separately. RESULTS: Moderately early, but not delayed, dexamethasone treatment significantly reduced mortality rates in trials with OLG use at CONCLUSIONS: When OLG use is taken into account moderately early dexamethasone treatment reduced mortality rates and the combined outcome mortality and BPD without increasing the risk of adverse neurodevelopmental outcome in ventilated preterm infants. A large randomized controlled trial is needed to confirm or refute these findings.Keywords
This publication has 40 references indexed in Scilit:
- Finding the Optimal Postnatal Dexamethasone Regimen for Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Systematic Review of Placebo-Controlled TrialsPediatrics, 2009
- Are postnatal steroids ever justified to treat severe bronchopulmonary dysplasia?Archives of Disease in Childhood - Fetal and Neonatal Edition, 2007
- Less postnatal steroids, more bronchopulmonary dysplasia: a population-based study in very low birthweight infantsArchives of Disease in Childhood - Fetal and Neonatal Edition, 2007
- The effects of non-compliance on intent-to-treat analysis of equivalence trialsStatistics in Medicine, 2005
- Effect of Dexamethasone on Tracheobronchial Aspirate Fluid Cytology and Pulmonary Mechanics in Preterm InfantsPharmacology, 2004
- How should meta‐regression analyses be undertaken and interpreted?Statistics in Medicine, 2002
- Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infantThe Journal of Pediatrics, 1995
- Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia.Archives of Disease in Childhood, 1993
- Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: A controlled trialThe Journal of Pediatrics, 1989
- A Controlled Trial of Dexamethasone in Preterm Infants at High Risk for Bronchopulmonary DysplasiaNew England Journal of Medicine, 1989